Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen

Centrum für Thrombose und Hämostase (CTH)

Klinikum / Johannes Gutenberg-Universität Mainz

Publikationen
Ergebnisse pro Seite:  10

Jurk, K.; Hausding, M.; Muenzel, T. et al.

CD40L deficiency protects from a pro-thrombotic phenotype induced by angiotensin-II in mice

JOURNAL OF THROMBOSIS AND HAEMOSTASIS. Bd. 11. 2013 S. 278-278


Wagner, Nana-Maria; Brandhorst, Gunnar; Czepluch, Frauke et al.

Circulating Regulatory T Cells Are Reduced in Obesity and May Identify Subjects at Increased Metabolic and Cardiovascular Risk

OBESITY. Bd. 21. H. 3. 2013 S. 461-468


Schweigel, Hardy; Geiger, Joerg; Beck, Florian et al.

Deciphering of ADP-induced, phosphotyrosine-dependent signaling networks in human platelets by Src-homology 2 region (SH2)-profiling

PROTEOMICS. Bd. 13. H. 6. 2013 S. 1016-1027



Brandt, M.; Schoenfelder, T.; Schwenk, M. et al.

Deep vein thrombus formation induced by flow reduction in mice is determined by venous side branches

JOURNAL OF THROMBOSIS AND HAEMOSTASIS. Bd. 11. 2013 S. 493-493


Begonja, Antonija Jurak; Gambaryan, Stepan; Schulze, Harald et al.

Differential roles of cAMP and cGMP in megakaryocyte maturation and platelet biogenesis

EXPERIMENTAL HEMATOLOGY. Bd. 41. H. 1. 2013 S. 91-101


Rukoyatkina, N.; Mindukshev, I.; Walter, U. et al.

Dual role of the p38 MAPK/cPLA(2) pathway in the regulation of platelet apoptosis induced by ABT-737 and strong platelet agonists

CELL DEATH & DISEASE. Bd. 4. 2013


Erdmann, J; Stark, K; Esslinger, UB et al.

Dysfunctional nitric oxide signalling increases risk of myocardial infarction

Nature. 2013 S. 1-8


Erdmann, Jeanette; Stark, Klaus; Esslinger, Ulrike B. et al.

Dysfunctional nitric oxide signalling increases risk of myocardial infarction

NATURE. Bd. 504. H. 7480. 2013 S. 432-+


Tziakas, Dimitrios; Chalikias, Georgios; Kapelouzou, Alkistis et al.

Erythrocyte membrane cholesterol and lipid core growth in a rabbit model of atherosclerosis: Modulatory effects of rosuvastatin

INTERNATIONAL JOURNAL OF CARDIOLOGY. Bd. 170. H. 2. 2013 S. 173-181